[HTML][HTML] The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases

C de Torre-Minguela, P Mesa del Castillo… - Frontiers in …, 2017 - frontiersin.org
Inflammasomes are multiprotein complexes that critically control different aspects of innate
and adaptive immunity. Among them we could highlight the release of pro-inflammatory …

Familial Mediterranean fever, review of the literature

M Alghamdi - Clinical rheumatology, 2017 - Springer
Familial Mediterranean fever (FMF) is the most common monogenic periodic fever syndrome
and characterized by recurrent episodes of fever, serositis, arthritis, dermal manifestations …

[HTML][HTML] Canakinumab for the treatment of autoinflammatory recurrent fever syndromes

F De Benedetti, M Gattorno, J Anton… - … England Journal of …, 2018 - Mass Medical Soc
Abstract Background Familial Mediterranean fever, mevalonate kinase deficiency (also
known as the hyperimmunoglobulinemia D syndrome), and the tumor necrosis factor …

[HTML][HTML] Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management

S Özen, ED Batu, S Demir - Frontiers in immunology, 2017 - frontiersin.org
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory
disease (AID) affecting mainly the ethnic groups originating from Mediterranean basin. The …

Familial mediterranean fever

H Ozdogan, S Ugurlu - La Presse Médicale, 2019 - Elsevier
Summary Familial Mediterranean Fever (FMF) is the oldest and the most frequent of all
described hereditary periodic fever syndromes. The populations originating from …

[HTML][HTML] Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments

S Ozen, I Kone-Paut, A Gül - Seminars in arthritis and rheumatism, 2017 - Elsevier
Abstract Background Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory
syndrome characterized by recurrent serositis or arthritis attacks and, in some patients …

[HTML][HTML] IL-1 inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives

H Malcova, Z Strizova, T Milota, I Striz… - Frontiers in …, 2021 - frontiersin.org
Autoinflammatory diseases (AIDs) represent a rare and heterogeneous group of disorders
characterized by recurrent episodes of inflammation and a broad range of clinical …

[HTML][HTML] Potential of IL-1, IL-18 and inflammasome inhibition for the treatment of inflammatory skin diseases

G Fenini, E Contassot, LE French - Frontiers in pharmacology, 2017 - frontiersin.org
In 2002, intracellular protein complexes known as the inflammasomes were discovered and
were shown to have a crucial role in the sensing of intracellular pathogen-and danger …

Periodic fever syndromes

HJ Lachmann - Best practice & research Clinical rheumatology, 2017 - Elsevier
Periodic fever syndromes are autoinflammatory diseases. The majority present in infancy or
childhood and are characterised by recurrent episodes of fever and systemic inflammation …

Current therapeutic options for the main monogenic autoinflammatory diseases and PFAPA syndrome: evidence-based approach and proposal of a practical guide

A Soriano, M Soriano, G Espinosa, R Manna… - Frontiers in …, 2020 - frontiersin.org
Monogenic autoinflammatory diseases are rare conditions caused by genetic abnormalities
affecting the innate immunity. Previous therapeutic strategies had been mainly based on …